Clinical Trial Update: Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating desvenlafaxine succinate sustained-release (DVS SR) for peri- and postmenopausal women with major depressive disorder has completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Desvenlafaxine succinate sustained-release (DVS SR) (desvenlafaxine succinate)

Snippet

Sponsor: Pfizer | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED | Results posted: 2012-03-30